Difference between revisions of "Part:BBa K3858014"
(→Usage and Biology) |
|||
Line 7: | Line 7: | ||
<!-- Add more about the biology of this part here --> | <!-- Add more about the biology of this part here --> | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | In 2021, GreatBay_United tried to display this antibody onto the yeast surface. | ||
+ | |||
+ | There are two kinds of construction: Solely expression the antibody or fusion expression with GFP. To display onto surface, an existing part ([[Part:BBa_K416000|Aga2]]) were used to lead the recombination protein to the cell membrane.<br> | ||
+ | |||
+ | [[File:T--Greatbay United--p003.png|600px|thumb|center|anti-GFP expression cassette]] | ||
+ | |||
+ | For the fusion expression version, the GFP part and anti-GFP part were linked with HCV protease cutting site. Thus, if both complex and antiGFP were successfully displayed on the surface, they will be able to sense the HCV NS3 protease in solution. The protease would cut and release the antiGFP linked to GFP, and the solely expressed anti-GFP would had chance to connect with GFP. this interaction would lead to the macroscopical agglutination phenomenon when we mix two kinds of engineered yeast together and also HCV protease.<br> | ||
+ | |||
+ | [[File:T--Greatbay United--p004.png|600px|thumb|center|the cassette of yeast surface display of GFP-HCV protease cut site-antiGFP complex]] | ||
===Reference=== | ===Reference=== |
Revision as of 18:35, 20 October 2021
antiGFP-High encoding
Recombinant nanobody against GFP. High affinity compared with antiGFP-Low.
Usage and Biology
In 2021, GreatBay_United tried to display this antibody onto the yeast surface.
There are two kinds of construction: Solely expression the antibody or fusion expression with GFP. To display onto surface, an existing part (Aga2) were used to lead the recombination protein to the cell membrane.
For the fusion expression version, the GFP part and anti-GFP part were linked with HCV protease cutting site. Thus, if both complex and antiGFP were successfully displayed on the surface, they will be able to sense the HCV NS3 protease in solution. The protease would cut and release the antiGFP linked to GFP, and the solely expressed anti-GFP would had chance to connect with GFP. this interaction would lead to the macroscopical agglutination phenomenon when we mix two kinds of engineered yeast together and also HCV protease.
Reference
1. Fridy P C, Li Y, Keegan S, et al. A robust pipeline for rapid production of versatile nanobody repertoires[J]. Nature methods, 2014, 11(12): 1253-1260.
2. Toda S, McKeithan W L, Hakkinen T J, et al. Engineering synthetic morphogen systems that can program multicellular patterning[J]. Science, 2020, 370(6514): 327-331.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]